Brainsway Ltd (BRSYF)
OTHER OTC:BRSYF
US Market

Brainsway (BRSYF) Stock Price & Analysis

6 Followers

BRSYF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.90 - $2.97
Previous Close$2.1
Volume100.00
Average Volume (3M)1.50K
Market Cap
$118.15M
Enterprise Value$72.40M
Total Cash (Recent Filing)$45.98M
Total Debt (Recent Filing)$232.00K
Price to Earnings (P/E)
Beta13.51
Aug 06, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding33,242,189
10 Day Avg. Volume150
30 Day Avg. Volume1,500
Standard Deviation8.22
R-Squared0.01
Alpha1.05
Financial Highlights & Ratios
Price to Book (P/B)2.46
Price to Sales (P/S)2.20
Price to Cash Flow (P/CF)10.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.50
Enterprise Value/Gross Profit3.08
Enterprise Value/Ebitda-11.92
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

0.00%0.31%0.27%99.42%
0.00%
Insiders
0.27% Other Institutional Investors
99.42% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

BRSYF FAQ

What was Brainsway Ltd’s price range in the past 12 months?
Brainsway Ltd lowest stock price was $0.90 and its highest was $2.97 in the past 12 months.
    What is Brainsway Ltd’s market cap?
    Currently, no data Available
    When is Brainsway Ltd’s upcoming earnings report date?
    Brainsway Ltd’s upcoming earnings report date is Aug 06, 2024 which is in 10 days.
      How were Brainsway Ltd’s earnings last quarter?
      Brainsway Ltd released its earnings results on May 08, 2024. The company reported $0.003 earnings per share for the quarter, beating the consensus estimate of N/A by $0.003.
        Is Brainsway Ltd overvalued?
        According to Wall Street analysts Brainsway Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Brainsway Ltd pay dividends?
          Brainsway Ltd does not currently pay dividends.
          What is Brainsway Ltd’s EPS estimate?
          Brainsway Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Brainsway Ltd have?
          Brainsway Ltd has 33,335,083 shares outstanding.
            What happened to Brainsway Ltd’s price movement after its last earnings report?
            Brainsway Ltd reported an EPS of $0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Brainsway Ltd?
              Currently, no hedge funds are holding shares in BRSYF
              ---

              Brainsway Stock Smart Score

              Company Description

              Brainsway Ltd

              Brainsway Ltd. engages in the research, development and marketing of medical device for non-invasive treatment of the brain disorders. Its technology enables handling of a wide range of indications through the TMS Deep system developed by the company. Brainsway operates through the following segments: Major depression and Obsessive Compulsive Disorder (OCD). The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.
              ---

              BRSYF Earnings Call

              Q1 2024
              0:00 / 0:00
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Minerva Neurosciences
              InMode
              NovoCure
              Haemonetics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis